SCHEMBL21257375

SCHEMBL21257375

C[C@]1(COP(=O)(O)O)C[C@@H](n2cnc3c(N)nc(Cl)nc32)C[C@@H]1O

nearest known ligand 0.62

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ P2RY1 P47900 11/20 0.62
▸ P2RY2 P41231 1/20 0.53
▸ NT5E P21589 2/20 0.51
▸ P2RY11 Q96G91 2/20 0.47
▸ PNP P00491 1/20 0.46
▸ LMNA P02545 1/20 0.46
▸ TP53 P04637 1/20 0.46
▸ HTT P42858 1/20 0.46
▸ PDE4D Q08499 1/20 0.46
▸ PDE3A Q14432 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ RXFP1 Q9HBX9 1/20 0.46
▸ ADORA3 P0DMS8 3/20 0.46
▸ HSP90AA1 P07900 1/20 0.46
▸ HSP90B1 P14625 1/20 0.46
▸ ADORA2A P29274 1/20 0.46
▸ ADORA1 P30542 1/20 0.46
▸ TMEM97 Q5BJF2 1/20 0.46
▸ SIGMAR1 Q99720 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21100457 0.92 P2RY1 (0.65) P2RY1P2RY2NT5EP2RY11PNP
SCHEMBL21100284 0.84 ADORA3 (0.57) P2RY1PNPLMNATP53HTT
SCHEMBL16258261 0.84 P2RY1 (0.66) P2RY1P2RY2NT5EP2RY11ADORA3
SCHEMBL21100587 0.83 P2RY1 (0.53) P2RY1P2RY2NT5EP2RY11
SCHEMBL21100303 0.81 P2RY1 (0.52) P2RY1P2RY2NT5EP2RY11
Phosphoric Acid SCHEMBL21050274 0.80 P2RY1 (0.49) P2RY1P2RY2NT5EADORA3HSP90AA1
Phosphoric Acid SCHEMBL21050227 0.80 P2RY1 (0.49) P2RY1P2RY2NT5EADORA3HSP90AA1
SCHEMBL21050273 0.78 P2RY1 (0.62) P2RY1P2RY2NT5EP2RY11HSP90AA1
SCHEMBL21050226 0.78 P2RY1 (0.62) P2RY1P2RY2NT5EP2RY11HSP90AA1
SCHEMBL19503300 0.78 P2RY1 (0.67) P2RY1P2RY2NT5EP2RY11ADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019157317-A1 COMPOUNDS AND METHODS FOR TREATING ADDICTION AND RELATED DISORDERS ASTROCYTE PHARMACEUTICALS, INC. (US) 2019-08-15 — — WO disclosed
Send feedback